Trial Profile
PGT104 - A phase I trial of XYOTAX(TM) [paclitaxel poliglumex; Cell Therapeutics], cisplatin and radiation for esophageal and gastric cancer
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 13 Nov 2005
Price :
$35
*
At a glance
- Drugs Paclitaxel poliglumex (Primary) ; Cisplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 13 Nov 2005 New trial record.